BE900038A - Agents antidepression a base de 1,2,4-triazol-3-one. - Google Patents
Agents antidepression a base de 1,2,4-triazol-3-one.Info
- Publication number
- BE900038A BE900038A BE0/213240A BE213240A BE900038A BE 900038 A BE900038 A BE 900038A BE 0/213240 A BE0/213240 A BE 0/213240A BE 213240 A BE213240 A BE 213240A BE 900038 A BE900038 A BE 900038A
- Authority
- BE
- Belgium
- Prior art keywords
- triazol
- dihydro
- propyl
- ethyl
- agents based
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Méthode de préparation des composées de formule (I) ou de sels d'addition d'acides pharmaceutiquement acceptables de celui-ci, par exemple la 2-(3-((4-(3-chlorophényl)-1-pipérazinyl))propyl)-5-éthyl-2, 4-dihydro-4-(3-phénoxypropyl)-3H-1, 2, 4-triazol-3-one; la 2-(3-((4-(3-chlorophnyl)-1-pipérazinyl)) propyl)-5-éthyl-2, 4-dihydro-4-(4-phénoxybutyl)-3H-1, 2, 4-triazol-3-one; la 2-(3-((4-(3-chlorophényl)-1-pipérazinyl)) propyl)-5-éthyl-2,4-dihydro-4-(2-méthoxyphénoxyéthyl)-3H-1, 2,4-triazol-3-one. Méthode de traitement d'un mammifère souffrant d'une dépression.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/509,266 US4487773A (en) | 1981-03-16 | 1983-06-29 | 1,2,4-Triazol-3-one antidepressants |
Publications (1)
Publication Number | Publication Date |
---|---|
BE900038A true BE900038A (fr) | 1984-12-28 |
Family
ID=24025922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/213240A BE900038A (fr) | 1983-06-29 | 1984-06-28 | Agents antidepression a base de 1,2,4-triazol-3-one. |
Country Status (21)
Country | Link |
---|---|
US (1) | US4487773A (fr) |
JP (1) | JPS6036469A (fr) |
KR (1) | KR890000637B1 (fr) |
AU (1) | AU579826B2 (fr) |
BE (1) | BE900038A (fr) |
CA (1) | CA1255310A (fr) |
CH (2) | CH663412A5 (fr) |
DE (1) | DE3423898A1 (fr) |
DK (1) | DK316784A (fr) |
ES (1) | ES533753A0 (fr) |
FI (1) | FI842597A (fr) |
FR (1) | FR2551439B1 (fr) |
GB (4) | GB2142631B (fr) |
GR (1) | GR81450B (fr) |
IT (1) | IT1176342B (fr) |
LU (1) | LU85442A1 (fr) |
MY (1) | MY102072A (fr) |
NL (1) | NL8402028A (fr) |
PT (1) | PT78816A (fr) |
SE (1) | SE8403460L (fr) |
ZA (1) | ZA844887B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU44721B (en) * | 1983-11-30 | 1990-12-31 | Bristol Myers Co | Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone |
US4596884A (en) * | 1983-11-30 | 1986-06-24 | Bristol-Myers Company | 4-(2-phenoxyethyl)-1,2,4-triazolone process intermediates |
DE3934081A1 (de) * | 1989-10-12 | 1991-04-18 | Bayer Ag | Sulfonylaminocarbonyltriazolinone |
US4784998A (en) * | 1987-04-06 | 1988-11-15 | Bristol-Myers Company | 1,3,4-oxadiazole pyschotropic compounds |
EP0350145A3 (fr) * | 1988-04-28 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Derivés de Pyridylthiazolidine carboxamide et intermédiaires et leur production |
FR2642759B1 (fr) * | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
US5243051A (en) * | 1990-03-05 | 1993-09-07 | Shionigi & Co., Ltd. | Tetrahydropyridine derivatives |
US5149817A (en) * | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
US5256664A (en) * | 1992-04-28 | 1993-10-26 | Bristol-Myers Squibb Company | Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
DE4425144A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Triazolverbindungen und deren Verwendung |
CA2160423A1 (fr) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Sels de nefazodone a taux de dissolution ameliores |
US6403593B1 (en) | 1995-07-14 | 2002-06-11 | Abbott Laboratories | Triazole compounds and the use thereof |
DE19728996A1 (de) | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
DE69928542T2 (de) | 1998-09-18 | 2006-03-30 | Alcon Manufacturing Ltd., Fort Worth | 5HT2-Agonisten zur Behandlung des Glaukoms |
ES2152860B1 (es) | 1998-10-23 | 2001-08-16 | Finaf 92 Sa | Forma cristalina de la nefazodona y procedimiento para su preparacion. |
ES2188344B1 (es) * | 2000-11-29 | 2004-09-16 | Laboratorios Vita, S.A. | Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos. |
MXPA05003830A (es) * | 2002-10-11 | 2005-06-23 | Cytokinetics Inc | Compuestos, composiciones y metodos. |
AU2004236195A1 (en) * | 2003-04-30 | 2004-11-18 | Bayer Cropscience Ag | Phenyl substituted cyclic derivatives |
EP1737473A4 (fr) * | 2004-04-19 | 2009-08-26 | Noven Therapeutics Llc | Combinaisons de lithium et utilisations associees |
AR049382A1 (es) * | 2004-05-18 | 2006-07-26 | Fmc Corp | Derivados de la urea ciclica substituida |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
JP5358571B2 (ja) * | 2007-08-07 | 2013-12-04 | プロサリク リミテッド | セロトニン作動性調節因子としての1,2,4−トリアゾール誘導体 |
US8686158B2 (en) * | 2008-06-05 | 2014-04-01 | President And Fellows Of Harvard College | High-valent palladium fluoride complexes and uses thereof |
KR20110095898A (ko) | 2008-11-20 | 2011-08-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 유기 화합물의 플루오르화 |
JP2012514655A (ja) * | 2009-01-09 | 2012-06-28 | プレジデント アンド フェローズ オブ ハーバード カレッジ | フッ素含有化合物およびその使用法 |
EP2697204B1 (fr) | 2011-04-12 | 2017-03-08 | President and Fellows of Harvard College | Fluoration de composés organiques |
EP2822931B1 (fr) | 2012-03-09 | 2017-05-03 | Inception 2, Inc. | Composés de triazolone et leurs utilisations |
WO2014052622A1 (fr) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Complexes de fluoration de nickel et leurs utilisations |
CN104918922B (zh) | 2012-12-20 | 2017-04-26 | 因森普深2公司 | 三唑酮化合物及其用途 |
EP2990082B1 (fr) | 2013-04-26 | 2017-06-07 | Nippon Takkyu Co., Ltd. | Balle de tennis de table et composition de résine thermoplastique pour balle de tennis de table |
WO2015035059A1 (fr) | 2013-09-06 | 2015-03-12 | Inception 2, Inc. | Composés de triazolone et leurs utilisations |
US10759764B2 (en) | 2013-10-18 | 2020-09-01 | President And Fellows Of Harvard College | Fluorination of organic compounds |
WO2023218251A1 (fr) * | 2022-05-10 | 2023-11-16 | Clearsynth Labs Limied | Nouveaux analogues du néfazodone enrichis en deutérium et leur procédé de préparation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
IT1052119B (it) * | 1972-10-16 | 1981-06-20 | Sigma Tau Ind Farmaceuti | Derivati del triazolinone e procedimento per la loro preparazione |
IT1052130B (it) * | 1973-10-15 | 1981-06-20 | Sigma Tau Ind Farmaceuti | Derivati del triazolinone e procedimento per la loro preparazione |
US4338317A (en) * | 1981-03-16 | 1982-07-06 | Mead Johnson & Company | Phenoxyethyl-1,2,4,-triazol-3-one antidepressants |
US4386091A (en) * | 1982-02-24 | 1983-05-31 | Mead Johnson & Company | 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants |
US4613600A (en) * | 1983-09-30 | 1986-09-23 | Mead Johnson & Company | Antidepressant 1,2,4-triazolone compounds |
-
1983
- 1983-06-29 US US06/509,266 patent/US4487773A/en not_active Expired - Fee Related
-
1984
- 1984-06-26 GR GR75111A patent/GR81450B/el unknown
- 1984-06-26 ZA ZA844887A patent/ZA844887B/xx unknown
- 1984-06-27 FR FR848410136A patent/FR2551439B1/fr not_active Expired
- 1984-06-27 CA CA000457534A patent/CA1255310A/fr not_active Expired
- 1984-06-27 ES ES533753A patent/ES533753A0/es active Granted
- 1984-06-27 NL NL8402028A patent/NL8402028A/nl not_active Application Discontinuation
- 1984-06-27 FI FI842597A patent/FI842597A/fi not_active Application Discontinuation
- 1984-06-27 AU AU29953/84A patent/AU579826B2/en not_active Ceased
- 1984-06-28 CH CH1910/87A patent/CH663412A5/de not_active IP Right Cessation
- 1984-06-28 PT PT78816A patent/PT78816A/pt not_active IP Right Cessation
- 1984-06-28 KR KR1019840003692A patent/KR890000637B1/ko not_active IP Right Cessation
- 1984-06-28 SE SE8403460A patent/SE8403460L/xx not_active Application Discontinuation
- 1984-06-28 IT IT21641/84A patent/IT1176342B/it active
- 1984-06-28 GB GB08416435A patent/GB2142631B/en not_active Expired
- 1984-06-28 LU LU85442A patent/LU85442A1/fr unknown
- 1984-06-28 BE BE0/213240A patent/BE900038A/fr not_active IP Right Cessation
- 1984-06-28 CH CH3130/84A patent/CH662562A5/de not_active IP Right Cessation
- 1984-06-28 DE DE19843423898 patent/DE3423898A1/de not_active Ceased
- 1984-06-28 DK DK316784A patent/DK316784A/da not_active Application Discontinuation
- 1984-06-29 JP JP59133401A patent/JPS6036469A/ja active Granted
-
1987
- 1987-02-17 GB GB08703634A patent/GB2185021B/en not_active Expired
- 1987-02-17 GB GB08703633A patent/GB2184447B/en not_active Expired
- 1987-02-17 GB GB08703632A patent/GB2184446A/en not_active Withdrawn
- 1987-09-29 MY MYPI87002184A patent/MY102072A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE900038A (fr) | Agents antidepression a base de 1,2,4-triazol-3-one. | |
ES2029812T3 (es) | Un procedimiento para preparar alfa-alquil-4-amino-3-quinolina-metanoles y 1-(4-aralquilamino-3-quinolil)alcanonas. | |
LU88749I2 (fr) | TACRINE et ses dérivés pharmaceutiquement acceptables (COGNEX) | |
KR880009910A (ko) | 리폭시게네이즈 억제 화합물 | |
NO870378L (no) | 5,6-dihydro-2-(substituert fenyl)-1,2,4-triazin-3,5(2h,5h)-dioner. | |
FI931765A0 (fi) | Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar | |
MY104335A (en) | 4-aminophridine deravatives | |
SE8505715D0 (sv) | Indolderivat | |
DE3564105D1 (en) | Novel substituted pyrrolidinones, process for their manufacture and pharmaceutics | |
KR880003920A (ko) | 피리다지논 유도체 | |
KR960017663A (ko) | 결합 수용체 길항물질 | |
PH25106A (en) | 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof | |
FI955387A0 (fi) | 4(p-fluorifenyyli)-3-((3,4-(metyleenioksi)fenoksi)metyyli)-piperidiinin N-p-halobentsoyylimetyylijohdannaiset | |
NO177053C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive (1,2,3,4-tetrahydro-9-akridinimino)cykloheksankarboksylsyrer | |
ES550871A0 (es) | Un procedimiento para preparar nuevos derivados del 1,3-ben-zoxatiol | |
EA199900667A1 (ru) | Замещенный 4-(6-фтор-(1h)-индол-3-ил)-1,2,3,6-тетрагидропиридин для лечения нарушений цнс | |
NO902556D0 (no) | 4,5,5a,6-tetrahydro-3h-isoksazol(5,4,3-kl)akridinderivater og fremgangsmaate for fremstilling derav. | |
YU46441B (sh) | Postupak za dobijanje 8{-/4-(2-pirimidinil)-1-piperazinil/butil}-8-aza-1-spiro/4,5/-dekan-7,9-diona | |
MD980029A (en) | New derivatives of the spiro-[2H-1-benzopyrane-2,4ó-piperidin]-4(3H)-on, acid-additive salts thereof and pharmaceutical compositions containing them | |
NZ240298A (en) | 4-(4- and/or 6-(trifluoromethyl)pyrid-2-)piperazin-1-ylalkyl substituted lactam derivatives | |
FR2823749B1 (fr) | Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
CA2251637A1 (fr) | Nouveaux [2-(1-piperazinyl)ethoxy]methyle substitues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: BRISTOL-MYERS CY Effective date: 19930630 |